No ice? No problem. San Diego biotech sees global potential in its sturdy COVID-19 vaccine

Published by
The San Diego Union-Tribune

Inovio Pharmaceuticals told investors and The San Diego Union-Tribune this week that it’s forging ahead with global trials of a coronavirus vaccine it says is well-suited to reach those living in rural communities, low-income countries and other remote areas. That’s because the biotech’s vaccine can be stored at room temperature for more than a year. By comparison, Moderna’s vaccine must be kept in a freezer, and Pfizer’s shots require ultracold storage of around -112 degrees Fahrenheit — chillier than the lowest temperature ever recorded in Antarctica. And while wealthier nations have the dee…

Read More

Post Author: